Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Hematological manifestations of Good syndrome

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Hematological manifestations of Good syndrome.


  1. 1.

    Gurnari C, Durrani J, Pagliuca S, Kishtagari A, Awada H, Kerr CM, et al. Novel invariant features of Good syndrome. Leukemia. 2021.

  2. 2.

    Kelesidis T, Yang O. Good’s syndrome remains a mystery after 55 years: a systematic review of the scientific evidence. Clin Immunol. 2010;135:347–63.

    CAS  Article  Google Scholar 

  3. 3.

    Jansen A, van Deuren M, Miller J, Litzman J, de Gracia J, Sáenz-Cuesta M, et al. Prognosis of Good syndrome: mortality and morbidity of thymoma associated immunodeficiency in perspective. Clin Immunol. 2016;171:12–17.

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Chen Wang.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, C., Shi, Y. Hematological manifestations of Good syndrome. Leukemia (2021).

Download citation


Quick links